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Summary In an observational follow-up study we determined whether the combined use of mammography and breast ultrasonography is an
appropriate diagnostic tool to select patients with symptomatic breast disease who need additional pathological evaluation. Mammography
and ultrasound were used as complementary diagnostic modalities in 3014 consecutively referred and mainly symptomatic patients.
Sensitivity, specificity, predictive values and likelihood ratios were calculated according to standard procedures. Virtually complete follow-up
was obtained by correlating the radiological diagnosis with clinical records, final pathological findings, records from the Cancer Register and
data from questionnaires sent to the general practitioners of all the referred patients. After an average follow-up period of 30 months, the
sensitivity for breast cancer detection was 92.0% and the specificity 97.7%. A positive predictive value of 68.0%, a negative predictive value
of 99.6%, a positive likelihood ratio of 40 and a negative likelihood ratio of 0.08 were found. The mean diagnostic delay as a result of false
negative examinations was 9 months (range 0-20 months). We conclude that breast imaging in routine daily practice, consisting of the
integral use of mammography and ultrasonography, is an appropriate tool in the detection of cancer and should be included in the work-up of
symptomatic breast disease.
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In many Western countries breast cancer is the most common
cause of death in women aged 35-55. The sensitivity and speci-
ficity ofmammography in the detection ofbreast cancerhave been
reported in several screening studies (Tabar et al, 1984; Baines et
al, 1986; Bird, 1989; Sickles et al, 1990; Robertson, 1993) and
diagnostic (consultative) studies (Wolfe et al, 1987; Hansell et al,
1988; Reintgen et al, 1993; Robertson, 1993; Sienko et al, 1993).
However, in diagnostic studies, these parameters have frequently
been determined retrospectively in pathologically proven breast
cancers (Hansell et al, 1988; Reintgen et al, 1993). Moreover, the
follow-up period has usually been 12 months or less (Wolfe et al,
1987; Robertson, 1993), and the proportion of patients lost to
follow-up has not been well defined in many ofthe studies (Baines
et al, 1986; Bird, 1989; Sienko et al, 1993). For these reasons, the
actual sensitivity and specificity ofbreast imaging in the detection
ofbreast cancer will be lower than reported.
The value ofultrasound examination ofthe breast as an adjunct
to mammography, in the work-up of symptomatic breast disease
is well established (Fleischer et al, 1983; Bassett et al, 1987;
Warwick et al, 1988; Jackson, 1995). No prospective series with
well-specified follow-up have been published in which both
modalities are used as an integrated approach to determine the
sensitivity and specificity in symptomatic patients.
Toovercome therestrictions mentioned, weperformed aprospec-
tive study with extensive follow-up of over 3000 consecutive
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diagnostic examinations to estimate the sensitivity, specificity,
predictive values and likelihood ratios of breast imaging in the
detection of cancer in a normal care, heterogeneous population. In
this study we used mammography and ultrasound as complemen-
tary diagnostic modalities.
METHODS
We included all patients, referred for breast imaging to the depart-
ment of radiology of an urban teaching hospital by physicians
between 1 January 1992 and 1 January 1994. The principal reason
for breast imaging was derived from the referral.
Under the age of 25 years, an ultrasound (US) examination by
means of a 7.5-mHz, linear array scanner (Aloka SSD-650; Aloka,
Tokyo, Japan) was performed iflocal pain or a breast mass was the
presenting symptom. If a young patient underwent breast imaging
for other reasons a one-view mammogram (mediolateral oblique)
of each breast was obtained. Older patients initially underwent
mammography. This consisted ofa two-view examination (cranio-
caudal and mediolateral oblique) and additional local compression
or magnification mammograms if necessary. The mammograms
were obtained with a commercially available unit (Mammomat-2,
Siemens, Erlangen, Germany) using focal spot sizes of 0.4 mm
and 0.15 mm, grids and extended-cycle dedicated processing.
Indications for performing ultrasonography afterwards were (a)
evaluation of non-conclusive mammographic findings (e.g. to
differentiate solid from cystic masses or evaluation of an asym-
metric mammographic density that could be due to an underlying
circumscribed mass) and (b) evaluation ofapalpable mass orlocal-
ized breast pain when the mammogram was negative. The exami-
nations were assessed by one of three radiologists, each having
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Table 1 Age distribution of the study population
Age (years) Number (%)
< 30 223 (7.4)
31-40 482 (16.0)
41-50 995 (33.0)
51-60 683 (22.7)
61-70 386 (12.8)
. 71 245 (8.1)
Total 3014 (100)
Table 2 Sensitivity, specificity, predictive values and likelihood ratios of
breast imaging
Biopsylfollow-up result
Radiological diagnosis Carcinoma No carcinoma Total
Suspicious or malignant 138 65 203
Normal, benign or probably benign 12 2799 2811
Total 150 2864 3014
Sensitivity, 92.0% (138 out of 150); specificity, 97.7% (2799 out of 2864).
Positive predictive value, 68.0% (138 out of 203); negative predictive value,
99.6% (2799 out of 2811). Positive likelihood ratio, 40 (92/(100-97.7);
negative likelihood ratio = 0.08 (100-92)/97.7).
over 10 years ofbreast imaging experience and interpreting 450 or
more examinations per year. The mammographic and sonographic
diagnoses were formulated using described criteria (Harper et al,
1983; Egan and Egan, 1984; Tabar and Dean, 1985; Fornage et al,
1989). Double reading of all examinations was performed and the
final radiological diagnosis was reached by consensus.
Radiological diagnosis was classified into five groups: (1)
normal (no apparent abnormalities); (2) benign (e.g. simple cyst,
calcified fibroadenoma or mastopathy); (3) probably benign (e.g.
asymmetric area offibroglandular density or multiple discrete clus-
ters ofcalcifications); (4) suspicious (e.g. solid mass with irregular
or not well-defined borders); and (5) malignant (e.g. spiculated
mass or microcalcifications of the ductal type). Categorizations of
'normal', 'benign' and 'probably benign' were considered to be
negative radiology reports. 'Suspicious' and 'malignant' were
considered to be positive reports.
The follow-up period ended on 1 July 1995 and three follow-up
procedures were used to provide the best information possible
regarding the breast cancer status ofall patients in the study.
First, all general practitioners received a questionnaire by mail
concerning all their patients who underwent breast imaging in our
department during 1992 and 1993. They were asked if their
patients were still registered in their practice and whether (and
when) breast cancer had been diagnosed in another hospital. Ifthe
general practitioner had not returned the questionnaire within a
month, a reminder was sent. Finally, we made telephone calls to
those patients whose follow-up data were still incomplete.
Secondly, we received all the pathology reports of breast biop-
sies performed in our hospital between 1 January 1992 and 1 July
1995. The stage of disease was determined in all patients who
developed breast cancer during the observation period. Lobular
carcinoma in situ was not considered to be a cancer.
Finally, all patient files were linked to those of the Amsterdam
Integral Cancer Register (IKA). This third follow-up procedure
provided information on cases for which breast cancer was diag-
nosed in hospitals that were not already registered in our system.
Patients for whom the general practitioner mentioned as having
not developed breast cancer during the follow-up period and who
were not found in the pathology logbooks or IKA tumour register
were assumed not to have breast cancer.
Sensitivity, specificity, predictive values and likelihood ratios
were calculated according to standard procedures.
The radiological test was considered to be false negative if a
patient developed breast cancer within 1 year after a negative radi-
ology report. The radiological examinations of all patients in
whom breast cancer was diagnosed more than a year after a nega-
tive radiology report were reviewed by three radiologists who
knew that a carcinoma was present in one of the breasts. This
report was considered to be true negative only if there was a
consensus among the radiologists that there was no reason to
suggest malignancy and if there was no clinical suspicion of
cancer at the initial presentation ofthe patient.
Table 3 Characteristics of all false-negative cases
Age' Principal reason Radiological Pathology Diagnostic
(years) for breast imaging diagnosis delay (months)
Histologyb Tumour size (cm) Axillary nodes
33 BCSc Normal lDu 3.5 N- 11
34 Lumpy breasts Benign lDu 1.5 N+ 2
43 Dominant lump Benign lDu 2 N- 11
44 BCS Normal DCIS 1 ND 10
45 Discharge Probably benign DCIS 1.5 ND 6
47 Dominant lump Benign ILo 1.5 N- 0
49 Screening Benign DCIS 0.5 ND 14
50 Dominant lump Benign lDu 4 N- 3
53 Dominant lump Normal IDu 3 N+ 20
60 Screening Probably benign IDu 2.5 N+ 8
71 Mastectomy Normal IDu 1.8 N+ 18
76 Dominant lump Probably benign IPa 3 N- 6
aAge at initial radiological examination. bDominant type. cBreast conserving surgery. lDu, invasive ductal carcinoma; ILo, invasive lobular carcinoma; DCIS,
ductal carcinoma in situ; IPa, invasive papillary carcinoma. N-, axillary nodes negative; N+, axillary nodes positive; ND, axillary node dissection not done.
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RESULTS
Between 1 January 1992 and 1 January 1994, 3014 patients under-
went radiological breast imaging in our department. There were
2994 women and 20 men; from these patients 63% were referred
by general practitioners and 37% by specialists (mainly surgeons
and gynaecologists). Approximately 13% of them were asympto-
matic, while the remainder underwent breast imaging for various
reasons, ranging from a family history of breast cancer to evalua-
tion of a palpable abnormality. The average age was 50 years
(range 10-94 years; Table 1) and average follow-up time, as of 1
July 1995, was 30 months (range 18-42 months). The following
examinations were performed: mammography only, 1931; combi-
nation of mammography and ultrasound, 996; ultrasound only, 87.
The results ofthe radiology reports were as follows: normal, 2042
(67.8%); benign, 625 (20.7%); probably benign, 143 (4.7%); suspi-
cious, 96 (3.2%); malignant, 108 (3.6%). Thefollow-up procedures
provided complete follow-up data from 2987 patients (99.1%).
The incidence ofbreast cancer in the study population was 5%.
The sensitivity for breast cancer detection was 92.0% and the
specificity 97.7%. A positive predictive value of 68%, a negative
predictive value of 99.6%, a positive likelihood ratio of 40 and a
negative likelihood ratio of0.08 were found (Table 2).
Within 1 year after a negative radiology report, nine patients
were found to have breast cancer. Another 15 patients developed
breast cancer more than 1 year after anegative radiology report. In
three ofthese patients, the reviewing radiologists considered their
radiological examinations to be false negative. The remaining 12
patients showed neither clinical nor radiological signs of malig-
nancy at their initial presentation, and their radiology reports are
therefore considered to be true negative. Table 3 demonstrates the
characteristics of all 12 (nine plus three) false-negative cases. In
one of these patients, surgeons performed fine-needle aspiration
biopsy directly after the false-negative radiological examination,
and malignant cells were obtained. In the remaining 11 patients,
the diagnosis of biopsy-proven breast cancer (either by FNAB or
open biopsy) was established 2-20 months after the false-negative
radiology report. In four cases, biopsy was performed because of
an increasing clinical suspicion ofmalignancy and abnormal find-
ings at follow-up radiological examinations prompted biopsy in
seven patients.
Variations in diagnostic indexes according to the type of refer-
ring physician (general practitioner vs specialist) are shown in
Table 4. The incidence ofbreast cancerwas 4% higherin the group
referred by specialists (95% confidence interval 2.2-5.8). There
were no differences in sensitivity and specificity values between
the two populations.
Table 4 Variations in diagnostic indexes according to the type of referring
physician
Referred by general Referred by
practitioners specialists
Breast cancer incidence 3.5% 7.5%
Sensitivity 92.5% 91.6%
Specificity 97.8% 97.7%
Positive predictive value 60.2% 76.0%
Negative predictive value 99.7% 99.3%
Positive likelihood ratio 42 40
Negative likelihood ratio 0.08 0.09
The group of patients with a breast lump as the presenting
symptom comprised the majority of breast cancers (Table 5). The
incidence ofcancer in this population was 10%, the sensitivity and
specificity were both 95%. The number of cancers in the other
subgroups were too small for a reliable determination ofthe sensi-
tivity values.
The sensitivity increased with increasing age (from 80% in
patients aged 31-40 years to 96% in patients aged over 60 years;
further data not shown).
DISCUSSION
In our study, radiological breastimaging had a sensitivity of92.0%
and a specificity of97.7% in the detection ofcancer. It is difficult
to compare our results with those of other investigators because
studies use different populations, radiological tests and follow-up
procedures. Wolfe et al (1987) reported a sensitivity of91.1% and
a specificity of 89.9%. However, all patients had a follow-up of
only 12 months and therefore the actual sensitivity will have been
lower than the one calculated. After 12 months of follow-up, the
sensitivity ofour study was 94% and this dropped to 92.0% after a
mean follow-up of 30 months. Standertskjold-Nordenstam and
Svinhufvud (1980) likewise reported a sensitivity of 91.8%, but
follow-up information was not specified. Also, all patients were
symptomatic and the incidence of carcinoma in their series was
8.7%, which is higher than that in our study (5%). Locker et al
(1989) calculated a sensitivity of 88% in a symptomatic popula-
tion, but again follow-up information was not specified. In a
largely asymptomatic population Sienko et al (1993) reported a
sensitivity of 71% only and a specificity of 98%. In all studies
mentioned above ultrasound was not used in the radiological
work-up of breast disease. Ultrasonography plays an important
role in breast radiology. It should be performed as the initial
imaging study in younger women with a palpable mass and the
value ofultrasonographical guidance forinterventional procedures
is well established (Jackson, 1995). The use of ultrasonography
willhelp todifferentiate solid fromcystic masses, and itfrequently
demonstrates a palpable mass that is not detected by mammog-
raphy because ofdense fibroglandular breast tissue (Sickles et al,
1984; Rosner and Blaird, 1985). Therefore, sensitivity and speci-
ficity will be increased by using ultrasonography complementary
to mammography. Kaplan et al (1990) estimated a sensitivity of
Table 5 Value of breast imaging according to the presenting symptoms /
reason for breast imaging
Presenting symptoms or n TP TN FP FN
reason for breast imaging (n) (n) (n) (n)
Screening (no symptoms) 397 4 385 6 2
Breast lump 984 98 834 47 5
Pain alone 508 6 498 4 0
Lumpiness with or without pain 281 2 274 4 1
Family history of breast cancera 251 2 249 0 0
Follow-up after previous breast cancer 370 4 361 2 3
Nipple/skin problems 104 4 99 0 1
Otherb 119 18 99 2 0
aBreast cancer in at least one first-degree relative. bFor example breast
implants, follow-up of previous mammographic abnormality. TP, true positive
radiological examination; TN, true negative; FP, false positive; FN, false
negative.
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98% in alarge series in whichultrasound was used complementary
to mammography, but long-term follow-up was not available. This
major shortcoming was also present in two other studies, in which
a sensitivity of97% was reported (Guyer, 1988; Den Heeten et al,
1993). Our study is the first one that estimates the sensitivity,
specificity and predictive values of breast imaging using
mammography and ultrasonography as integrated diagnostic
modalities in a large number ofprospectively identified, consecu-
tive cases for which the follow-up data collection is virtually
complete. We think that, because of the follow-up procedures
applied and the complementary use of mammography and ultra-
sound, the values ofthe parameters obtained in our study are more
in agreement with everyday reality than the results published in
other series. The definition ofa false-negative radiological exami-
nation used can markedly affect the sensitivity value obtained.
Every mammographer knows of false-negative cases that were
visible on a given study but went undetected, perhaps for several
years. Unfortunately, there is no gold standard available with
which the presence or absence ofcancer can be determined unam-
biguously and thereby be used to measure the sensitivity ofbreast
imaging. In screening programmes, interval cancers are cancers
discovered between two screening examinations after a previous
screening did not result in a request to perform a biopsy of the
breast in which the cancer was subsequently found. Although
some of these interval cancers may have arisen de novo between
screenings, it seems unrealistic to assume that none was poten-
tially detectable at screening. The other extreme is to assume that
all of the cancers detected between screenings are false-negative
cases, i.e. cases in which mammography fails to detect a proven
cancer during the time of the trial. In several screening studies
(Frisell et al, 1987; Peeters et al, 1989), 50-60% of the interval
cancers areregarded as 'true' interval cancers (an obvious lesion is
observed on the diagnostic mammogram while no suspect signs
are seen on the previous screening mammogram). Our study does
not concern a screening programme and therefore the term
'interval cancer' can not be used. For purposes of analysis, we
considered all radiology reports ofpatients who developed breast
cancer within 1 year after a negative radiological examination to
be false negative. Negative radiology reports of patients initially
presenting without clinical and radiological suspicion of cancer,
and who after 1 year following these reports developed cancer,
were considered in retrospect to be true negative.
A positive predictive value of 68.0% for the whole study popu-
lation was found. The incidence ofbreast cancer was higher in the
group referred for breast imaging by specialists. This difference is
reflected in the higher positive predictive value for the patients
referred by specialists (76% vs 60%). Comparison with other
series is difficult as the positive predictive value ofbreast imaging
depends on several otherfactors as well (Kopans, 1992). However,
the integral use of mammography and ultrasonography will have
helped us to obtain a positive predictive value that was substan-
tially higher than in diagnostic studies in which ultrasound was not
used (Wolfe et al, 1987; Robertson, 1993; Sienko et al, 1993).
It has been demonstrated that mammographic follow-up can be
a safe alternative to biopsy in the cases of mammographically
detected, probably benign lesions (De Neef and Gandera, 1991;
Helvie et al, 1991; Sickles, 1991). In our study, 2% of patients (3
out of 143) with these lesions were shown to have breast cancer
and the diagnostic delay in these cases was 6-8 months. One of
these patients had positive axillary nodes, and we cannot assess
whether the delay has compromised the outcome for this patient.
On the other hand, additional pathological examination of all the
probably benign lesions would have yielded an unacceptably low
malignant-benign biopsy ratio. For these reasons we support the
statement that radiological follow-up ofprobably benign lesions is
a reasonable alternative to surgical biopsy.
Currently, various biopsy techniques are available for
(non)palpable breast lesions. We determined the value of breast
imaging and did not focus on additional biopsy techniques. In
qualified hands, the FNAB (fine-needle aspiration biopsy) works
reasonably well and open surgical biopsy can be avoided in many
cases (Azavedo et al, 1989; Hindle et al, 1993). Recent studies
suggest that core biopsy can be as accurate as open surgical biopsy
in the work-up of (non)palpable lesions (Elvecroq et al, 1993;
Parker et al, 1994). During the study period, core biopsy was not
routinely performed at ourhospital.
Five patients with a dominant lump and a negative radiology
report were shown to have breast cancer. These cancers couldhave
been diagnosed properly if representative pathological examina-
tion had been performed. Again, in our series, this approach would
have resulted in a very low malignant-benign biopsy ratio.
One patient presented with breast cancer more than 18 months
after a false-negative radiological test. As follow-up ranged
between 18 and 42 months in our series, we are not certain that the
minimum observation period of 18 months was sufficient for the
detection of all false-negative cases. Therefore, the actual sensi-
tivity and specificity might be slightly less than those calculated.
The outcome ofour study could be biased ifradiological examina-
tion was not performed before surgery in a substantial proportion
of the breast cancer patients. This would leave a relatively benign
population for breast imaging. However, at our hospital, breast
imaging is nearly always performed before possible pathological
examination in accordance with state of the art work-up of symp-
tomatic breast disease.
We conclude that breast imaging, consisting of the integral use
of mammography and ultrasonography, is a valuable tool in the
detection of cancer and should therefore be included in the work-
up ofsymptomatic breast disease.
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